5-136029132-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_000358.3(TGFBI):​c.77C>T​(p.Ala26Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000636 in 1,525,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

TGFBI
NM_000358.3 missense

Scores

2
6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.32

Publications

0 publications found
Variant links:
Genes affected
TGFBI (HGNC:11771): (transforming growth factor beta induced) This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. [provided by RefSeq, Jul 2008]
TGFBI Gene-Disease associations (from GenCC):
  • epithelial-stromal TGFBI dystrophy
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • granular corneal dystrophy type I
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • granular corneal dystrophy type II
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • lattice corneal dystrophy type I
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Reis-Bucklers corneal dystrophy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • Thiel-Behnke corneal dystrophy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • epithelial basement membrane dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.115766406).
BS2
High AC in GnomAd4 at 50 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFBINM_000358.3 linkc.77C>T p.Ala26Val missense_variant Exon 1 of 17 ENST00000442011.7 NP_000349.1 Q15582A0A0S2Z4Q2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFBIENST00000442011.7 linkc.77C>T p.Ala26Val missense_variant Exon 1 of 17 1 NM_000358.3 ENSP00000416330.2 Q15582
TGFBIENST00000504185.5 linkn.145C>T non_coding_transcript_exon_variant Exon 1 of 5 4
TGFBIENST00000506699.5 linkn.142C>T non_coding_transcript_exon_variant Exon 1 of 17 2
TGFBIENST00000507018.5 linkn.-8C>T upstream_gene_variant 5 ENSP00000421540.1 H0Y8M8

Frequencies

GnomAD3 genomes
AF:
0.000329
AC:
50
AN:
152202
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00118
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000912
AC:
11
AN:
120580
AF XY:
0.0000601
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.000252
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000342
AC:
47
AN:
1373056
Hom.:
0
Cov.:
31
AF XY:
0.0000221
AC XY:
15
AN XY:
677534
show subpopulations
African (AFR)
AF:
0.00128
AC:
38
AN:
29684
American (AMR)
AF:
0.000199
AC:
7
AN:
35214
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24730
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34588
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78158
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34020
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4120
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1075176
Other (OTH)
AF:
0.0000349
AC:
2
AN:
57366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000329
AC:
50
AN:
152202
Hom.:
0
Cov.:
32
AF XY:
0.000296
AC XY:
22
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.00118
AC:
49
AN:
41470
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.000438
ExAC
AF:
0.0000194
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Sep 17, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.77C>T (p.A26V) alteration is located in exon 1 (coding exon 1) of the TGFBI gene. This alteration results from a C to T substitution at nucleotide position 77, causing the alanine (A) at amino acid position 26 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T
Eigen
Benign
-0.044
Eigen_PC
Benign
0.056
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.69
T
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.12
T
MetaSVM
Uncertain
0.49
D
MutationAssessor
Benign
0.0
N
PhyloP100
2.3
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-1.3
N
REVEL
Uncertain
0.43
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.013
D
Polyphen
0.25
B
Vest4
0.13
MutPred
0.19
Loss of disorder (P = 0.0533);
MVP
0.92
MPC
0.043
ClinPred
0.060
T
GERP RS
4.5
PromoterAI
0.018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.24
gMVP
0.36
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs767993906; hg19: chr5-135364821; API